Journal List > J Rheum Dis > v.20(3) > 1064044

Nam, Moon, Lee, Park, Jang, Kim, Jeon, and Koh: A Case of Skin Sclerosis Associated with Docetaxel Chemotherapy for Non-Small Cell Lung Cancer

Abstract

A 64-year-old woman was diagnosed with non-small cell lung cancer. Her disease was stage 4 (T2N2M1) with squ-amous cell carcinoma. She had been treated with docetaxel and carboplatin. After a completion of 11 cycle of chemotherapy, edema appeared on both feet and had spread rapidly up to the pretibial area without response to diuretics. Sclerotic changes and pigmentation followed but both knees and other parts of the body were spared. There was no evidence of vascular occlusions. On serologic tests, antinuclear, anti-centromere, and anti-topoisomerase I antibodies were all negative. A skin biopsy revealed diffuse infiltration of lymphocytes and discretely thickened collagen bundles in the superficial dermis. After discontinuing docetaxel chemotherapy, she was treated with prednisolone and D-penicillamine and sclerotic changes on the lower legs were improved.

References

1. Trudeau ME. Docetaxel: a review of its pharmacology and clinical activity. Can J Oncol. 1996; 6:443–57.
2. Verweij J, Clavel M, Chevalier B. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind. Ann Oncol. 1994; 5:495–505.
3. Arwert L. Docetaxel-induced skin toxicity. Neth J Med. 2009; 67:33–4.
4. De Angelis R, Bugatti L, Cerioni A, Del Medico P, Filosa G. Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol. 2003; 22:49–52.
crossref
5. Farrant PB, Mortimer PS, Gore M. Scleroderma and the taxanes. Is there really a link? Clin Exp Dermatol. 2004; 29:360–2.
6. Sakkas LI, Moore DF, Akritidis NC. Cancer in families with systemic sclerosis. Am J Med Sci. 1995; 310:223–5.
7. Kim HJ, Seo YI, Kwon YS, Kim YM, Park EJ, Kim HA. A case of paclitaxel induced scleroderma in a patient with ovarian cancer. J Rheum Dis. 2011; 18:110–3.
crossref
8. Yoon JH, Choi K, Seo HI, Lee YS, Oh SJ, Lee SS. A case of paclitaxel induced scleroderma. Korean J Med. 2006; 70:S373–6.
9. Karim M, Vaux E, Davies DR, Mason PD. Renal failure due to scleroderma with thrombotic microangiopathy developing in a woman treated with carboplatin for ovarian cancer. Clin Nephrol. 2002; 58:384–8.
crossref
10. Wigley FM, Sule SD. Novel therapy in the treatment of scleroderma. Expert Opin Investig Drugs. 2001; 10:31–48.
crossref

Figure 1.
Low magnification findings show mild acnthosis and superficial perivascular Inflammatory cell infiltrate (H&E, ×40).
jrd-20-198f1.tif
Figure 2.
Reticular dermis show thickened collagen bundles (H&E, ×200).
jrd-20-198f2.tif
Figure 3.
Subcutaneous collagen is pale and eosinophilic with a few lymphocytic infiltrate & endothelial swelling (H&E, ×200).
jrd-20-198f3.tif
TOOLS
Similar articles